These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12022850

  • 1. Mechanism of acetylcholinesterase inhibition by fasciculin: a 5-ns molecular dynamics simulation.
    Tai K, Shen T, Henchman RH, Bourne Y, Marchot P, McCammon JA.
    J Am Chem Soc; 2002 May 29; 124(21):6153-61. PubMed ID: 12022850
    [Abstract] [Full Text] [Related]

  • 2. [The fasciculin-acetylcholinesterase interaction].
    Marchot P.
    J Soc Biol; 1999 May 29; 193(6):505-8. PubMed ID: 10783708
    [Abstract] [Full Text] [Related]

  • 3. Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex.
    Bourne Y, Taylor P, Marchot P.
    Cell; 1995 Nov 03; 83(3):503-12. PubMed ID: 8521480
    [Abstract] [Full Text] [Related]

  • 4. Electron paramagnetic resonance reveals altered topography of the active center gorge of acetylcholinesterase after binding of fasciculin to the peripheral site.
    Sentjurc M, Pecar S, Stojan J, Marchot P, Radić Z, Grubic Z.
    Biochim Biophys Acta; 1999 Mar 19; 1430(2):349-58. PubMed ID: 10082962
    [Abstract] [Full Text] [Related]

  • 5. Allosteric control of acetylcholinesterase catalysis by fasciculin.
    Radić Z, Quinn DM, Vellom DC, Camp S, Taylor P.
    J Biol Chem; 1995 Sep 01; 270(35):20391-9. PubMed ID: 7657613
    [Abstract] [Full Text] [Related]

  • 6. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
    Rosenberry TL, Rabl CR, Neumann E.
    Biochemistry; 1996 Jan 23; 35(3):685-90. PubMed ID: 8547248
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target.
    Harel M, Kleywegt GJ, Ravelli RB, Silman I, Sussman JL.
    Structure; 1995 Dec 15; 3(12):1355-66. PubMed ID: 8747462
    [Abstract] [Full Text] [Related]

  • 8. Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation.
    Eastman J, Wilson EJ, Cerveñansky C, Rosenberry TL.
    J Biol Chem; 1995 Aug 25; 270(34):19694-701. PubMed ID: 7649979
    [Abstract] [Full Text] [Related]

  • 9. Acetylcholinesterase: enhanced fluctuations and alternative routes to the active site in the complex with fasciculin-2.
    Bui JM, Tai K, McCammon JA.
    J Am Chem Soc; 2004 Jun 16; 126(23):7198-205. PubMed ID: 15186156
    [Abstract] [Full Text] [Related]

  • 10. The binding sites of inhibitory monoclonal antibodies on acetylcholinesterase. Identification of a novel regulatory site at the putative "back door".
    Simon S, Le Goff A, Frobert Y, Grassi J, Massoulié J.
    J Biol Chem; 1999 Sep 24; 274(39):27740-6. PubMed ID: 10488117
    [Abstract] [Full Text] [Related]

  • 11. Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin.
    Radić Z, Kirchhoff PD, Quinn DM, McCammon JA, Taylor P.
    J Biol Chem; 1997 Sep 12; 272(37):23265-77. PubMed ID: 9287336
    [Abstract] [Full Text] [Related]

  • 12. Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase.
    van den Born HK, Radić Z, Marchot P, Taylor P, Tsigelny I.
    Protein Sci; 1995 Apr 12; 4(4):703-15. PubMed ID: 7613468
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of mouse acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis of fasciculin.
    Marchot P, Bourne Y, Prowse CN, Bougis PE, Taylor P.
    Toxicon; 1998 Nov 12; 36(11):1613-22. PubMed ID: 9792178
    [Abstract] [Full Text] [Related]

  • 14. Site of fasciculin interaction with acetylcholinesterase.
    Radić Z, Duran R, Vellom DC, Li Y, Cervenansky C, Taylor P.
    J Biol Chem; 1994 Apr 15; 269(15):11233-9. PubMed ID: 8157652
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
    Szegletes T, Mallender WD, Thomas PJ, Rosenberry TL.
    Biochemistry; 1999 Jan 05; 38(1):122-33. PubMed ID: 9890890
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Allosteric control of acetylcholinesterase activity by monoclonal antibodies.
    Saxena A, Hur R, Doctor BP.
    Biochemistry; 1998 Jan 06; 37(1):145-54. PubMed ID: 9425034
    [Abstract] [Full Text] [Related]

  • 19. Nanosecond dynamics of acetylcholinesterase near the active center gorge.
    Boyd AE, Dunlop CS, Wong L, Radic Z, Taylor P, Johnson DA.
    J Biol Chem; 2004 Jun 18; 279(25):26612-8. PubMed ID: 15078872
    [Abstract] [Full Text] [Related]

  • 20. Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex.
    Radić Z, Taylor P.
    J Biol Chem; 2001 Feb 16; 276(7):4622-33. PubMed ID: 11036076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.